These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17400442)

  • 1. Obesity and prostate cancer: an ambiguous relationship.
    Augustin H
    Eur J Cancer; 2007 May; 43(7):1114-6. PubMed ID: 17400442
    [No Abstract]   [Full Text] [Related]  

  • 2. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of body mass index on PSA levels and the development, screening and treatment of prostate cancer.
    Skolarus TA; Wolin KY; Grubb RL
    Nat Clin Pract Urol; 2007 Nov; 4(11):605-14. PubMed ID: 17982437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, endogenous hormone metabolism, and prostate cancer risk: a conundrum of "highs" and "lows".
    Kaaks R; Stattin P
    Cancer Prev Res (Phila); 2010 Mar; 3(3):259-62. PubMed ID: 20179295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
    Capitanio U; Perrotte P; Hutterer GC; Suardi N; Jeldres C; Shariat SF; Duclos A; Arjane P; Montorsi F; Karakiewicz PI
    Int J Urol; 2009 Jan; 16(1):91-5. PubMed ID: 19054167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
    Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
    Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of obesity with prostate specific antigen and prostate specific antigen velocity in healthy young men.
    Chang IH; Han JH; Ahn SH
    J Urol; 2008 Mar; 179(3):886-90; discussion 890-1. PubMed ID: 18207169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and prostate cancer.
    Harv Mens Health Watch; 2007 Jan; 11(6):1-3. PubMed ID: 17323487
    [No Abstract]   [Full Text] [Related]  

  • 15. Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases.
    Rodriguez AR; Kapoor R; Pow-Sang JM
    J Urol; 2007 May; 177(5):1765-70. PubMed ID: 17437812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
    Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
    Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
    J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.
    van Roermund JG; Kok DE; Wildhagen MF; Kiemeney LA; Struik F; Sloot S; van Oort IM; Hulsbergen-van de Kaa CA; van Leenders GJ; Bangma CH; Witjes JA
    BJU Int; 2009 Aug; 104(3):321-5. PubMed ID: 19220264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is obesity a risk factor for prostate cancer?
    Goldstraw MA; Besrani D; Amoroso P; Kirby RS
    BJU Int; 2007 Oct; 100(4):726-8. PubMed ID: 17662082
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED;
    J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.